Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
Open accessAbstract
Background & aims The clinical manifestations of Crohn's disease (CD) are diverse, ranging from fibrostenosing small-bowel disease to colon-predominant inflammation. These distinctions may represent genetic, immunologic, and microbial heterogeneity. NOD2 gene mutations in CD have been described recently and may alter innate immune responses. We hypothesized that NOD2 mutations may be associated with distinct phenotypic expressions of CD.Methods Two cohorts of consecutively identified patients referred to an inflammatory bowel disease center (n = 142 collected between 1993 and 1996; n = 59 collected between 1999 and 2001) were genotyped for 3 single nucleotide variants of NOD2-R675W, G881R, and 3020insC-and phenotyped for disease behavior, disease location, and serum immune markers.Results Univariate analysis showed that CD-associated NOD2 variants were significantly associated with fibrostenosing disease in each cohort (P = 0.049 and P = 0.002, respectively). When both cohorts were analyzed together, the association between NOD2 variants and fibrostenosing disease was more significant (P = 0.001). These relationships were observed in both Jews and non-Jews. Forty-six percent of patients with fibrostenosing disease carried at least 1 of these alleles, compared with only 23.5% of patients without fibrostenosing disease (odds ratio, 2.8; 95% confidence interval, 1.6-5.2). Multivariate and conditioning analyses showed a primary association between NOD2 allelic variants and fibrostenosing disease, but not with small-bowel disease.Conclusions In this description of a genotype/phenotype correlation in CD patients and NOD2 variants, data suggest that variation in this gene contributes to the occurrence of fibrostenotic CD of the small bowel.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TLR2 or TLR4 ligands induce cytokine and chemokine secretion from cultured intestinal myofibroblasts.
“TLR2 or TLR4 ligands induce cytokine and chemokine secretion from cultured intestinal myofibroblasts159”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [159]
TLR4 was protective in the lung, as opposed to its pathogenic effect in gut and liver fibrosis.
“Interestingly, TLR4 was protective in the lung, as opposed to its pathogenic effect in gut and liver fibrosis127,159”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [159]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · see citing works
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · see citing works
Case-Control Studies: Design, Conduct, Analysis.
Youkeles, L., & Schlesselman, J. J. (1983) · Journal of the American Statistical Association · doi:10.2307/2288156 · Cited by 2,358 · see citing works
Allelic discrimination using fluorogenic probes and the 5′ nuclease assay
Livak, K. J. (1999) · Genetic Analysis Biomolecular Engineering · doi:10.1016/s1050-3862(98)00019-9 · Cited by 1,383 · see citing works
Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB
Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008072200 · Cited by 1,357 · see citing works
Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144 · see citing works
Gasché, C., Schölmerich, J., Brynskov, J., D’Haens, G., Hanauer, S. B., Irvine, J. E., Jewell, D. P., Rachmilewitz, D., Sachar, D. B., Sandborn, W. J., et al. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00002 · Cited by 1,135 · see citing works
Hampe, J., Cuthbert, A. P., Croucher, P. J. P., Mirza, M. M., Mascheretti, S., Fisher, S. A., Frenzel, H., King, K., Hasselmeyer, A., Macpherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,090 · see citing works
Lesage, S., Zouali, H., Cézard, J., Colombel, J., Bélaïche, J., Almer, S. H., Tysk, C., O'Morain, C. A., Gassull, M. A., Binder, V., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339432 · Cited by 992 · see citing works
CARD15 mutations in Blau syndrome
Miceli‐Richard, C., Lesage, S., Rybojad, M., Prieur, A., Manouvrier‐Hanu, S., Häfner, R., Chamaillard, M., Zouali, H., Thomas, G. D., & Hugot, J. (2001) · Nature Genetics · doi:10.1038/ng720 · Cited by 966 · see citing works
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W.-J., Ewe, K., & BÜSCHENFELDE, K.-H. M. Z. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 938 · see citing works
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.
Kutyavin, I., Afonina, I., Mills, A., Gorn, V., Lukhtanov, E., Belousov, E. S., Singer, M. J., Walburger, D., Lokhov, S. G., Gall, A., et al. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.655 · Cited by 858 · see citing works
Zhang, F. X., Kirschning, C., Mancinelli, R., Xu, X.-P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., & Arditi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7611 · Cited by 702 · see citing works
Cuthbert, A. P., Fisher, S. A., Mirza, M. M., King, K., Hampe, J., Croucher, P. J. P., Mascheretti, S., Sanderson, J. D., Forbes, A., Mansfield, J. C., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32415 · Cited by 696 · see citing works
Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1609 · Cited by 681 · see citing works
Self-citationFrequency of glucocorticoid resistance and dependency in Crohn's disease.
Munkholm, P., Langholz, E., Davidsen, M., et al. (1994) · Gut · doi:10.1136/gut.35.3.360 · Cited by 661 · see citing works
Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex
Correia, J. D. S., Soldau, K., Christen, U., Tobias, P. S., & Ulevitch, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009164200 · Cited by 649 · see citing works
The molecular classification of the clinical manifestations of Crohn's disease
Ahmad, T., Armuzzi, A., Bunce, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32413 · Cited by 622 · see citing works
Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides
Inohara, N., Ogura, Y., Chen, F. F., Muto, A., & Núñez, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009728200 · Cited by 532 · see citing works
Saxon, A., Shanahan, F., Landers, C. J., Ganz, T., & Targan, S. R. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80067-3 · Cited by 514 · see citing works
Self-citationBowie, A., & O'Neill, L. A. J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.508 · Cited by 495 · see citing works
Greenstein, A. J., Lachman, P., Sachar, D. B., et al. (1988) · Gut · doi:10.1136/gut.29.5.588 · Cited by 411 · see citing works
Jiang, Q., Akashi, S., Miyake, K., & Petty, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3541 · Cited by 320 · see citing works
Vasiliauskas, E. A., Kam, L. Y., Karp, L. C., et al. (2000) · Gut · doi:10.1136/gut.47.4.487 · Cited by 314 · see citing works
Self-citationVasiliauskas, E., Plevy, S. E., Landers, C. J., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964407 · Cited by 298 · see citing works
Self-citationSpecific antibody response to oligomannosidic epitopes in Crohn's disease
Sendid, B., Colombel, J., Jacquinot, P. M., Faille, C., Fruit, J., Cortot, A., Lucidarme, D., Camus, D., & Poulain, D. (1996) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.3.2.219-226.1996 · Cited by 236 · see citing works
Taylor, K. D., Yang, H., Landers, C. J., Rotter, J. I., Targan, S. R., Plevy, S. E., & Barry, M. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.23966 · Cited by 221 · see citing works
Self-citationGranulomatous Infections: Etiology and Classification
Zumla, A. I., & James, D. G. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.146 · Cited by 219 · see citing works
Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope
Cohavy, O., Bruckner, D. A., Gordon, L. K., Misra, R., Wei, B., Eggena, M., Targan, S. R., & Braun, J. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1542-1548.2000 · Cited by 205 · see citing works
Self-citationStallmach, A., Schuppan, D., Riese, H. H., Matthes, H., & Riecken, E. O. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90314-o · Cited by 186 · see citing works
Vermeire, S., Peeters, M., VLIETINCK, R. F., Joossens, S. B. A., Hond, E. D., Bulteel, V., Bossuyt, X., Geypens, B. J., & Rutgeerts, P. J. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200102000-00002 · Cited by 184 · see citing works
Mycobacterium aviumsubsp.paratuberculosisas one cause of Crohn’s disease
Chamberlin, W., Graham, D. Y., Hultén, K. G., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00933.x · Cited by 171 · see citing works
Probiotics and inflammatory bowel diseases
Schultz, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00812-6 · Cited by 165 · see citing works
Risk factors for early postoperative recurrence of Crohn's disease
Lautenbach, E., Berlin, J. A., & Lichtenstein, G. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70191-x · Cited by 162 · see citing works
Fibrogenesis IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models
Pucilowska, J. B., Williams, K. L., & Lund, P. K. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.4.g653 · Cited by 160 · see citing works
McKaig, B. C., Hughes, K. R., Tighe, P. J., & Mahida, Y. R. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00048.2001 · Cited by 155 · see citing works
Veltkamp, C., Tonkonogy, S. L., de Jong, Y. P., Albright, C. A., Grenther, W. B., Balish, E., Terhorst, C., & Sartor, R. B. (2001) · Gastroenterology · doi:10.1053/gast.2001.22547 · Cited by 148 · see citing works
Sutton, C. L., Yang, H., Li, Z., Rotter, J. I., Targan, S. R., & Braun, J. (2000) · Gut · doi:10.1136/gut.46.1.58 · Cited by 146 · see citing works
Self-citationVermeire, S., Joossens, S. B. A., Peeters, M., Monsuur, F., Mariën, G., Bossuyt, X., Groenen, P. M. A., VLIETINCK, R. F., & Rutgeerts, P. (2001) · Gastroenterology · doi:10.1053/gast.2001.22546 · Cited by 139 · see citing works
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats
Rath, H. C., Ikeda, J. S., Linde, H. J., Schölmerich, J., Wilson, K. H., & Sartor, R. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70127-7 · Cited by 135 · see citing works
Surgical recurrence of perforating and nonperforating Crohn's disease
Aeberhard, P., Berchtold, W., Riedtmann, H.-J., et al. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02048274 · Cited by 131 · see citing works
Vidrich, A., Lee, J., James, E. B., et al. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01541319 · Cited by 107 · see citing works
Cohavy, O., Harth, G., Horwitz, M. A., Eggena, M., Landers, C. J., Sutton, C. L., Targan, S. R., & Braun, J. G. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6510-6517.1999 · Cited by 99 · see citing works
Self-citationEggena, M., Cohavy, O., Parseghian, M. H., et al. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0340 · Cited by 84 · see citing works
Bacterial Regulation of Intestinal Immune Responses
MacDonald, T. T., & Pettersson, S. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200005000-00008 · Cited by 71 · see citing works
Kutyavin, I. V., LUKHTANOV, E. A., Gamper, H., et al. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.18.3718 · Cited by 52 · see citing works
French, N. S., & PETTERSSON, S. (2000) · Gut · doi:10.1136/gut.47.2.162 · Cited by 28 · see citing works
Can we influence fibrosis in Crohn's disease?
Assche, G. V. (2001) · PubMed · Cited by 12 · see citing works
Yang, H., Taylor, K. D., Lin, Y., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)83453-8 · Cited by 5 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Aeberhard P, Berchtold W, Riedtmann HJ, Stadelmann G. Surgi- cal recurrence of perforating and nonperforating Crohn's dis- ease. A study of 101 surgically treated patients. Dis Colon Rec- tum 1996;39:80 -87.
- Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, Shafran I, El-Zaatari FA. Review article: Mycobac- terium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther 2001;15:337-346. Received February 8, 2002. Accepted March 16, 2002.
Cited by
Sorted by citations
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · see citing works
Current Understanding of Dysbiosis in Disease in Human and Animal Models
DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000750 · Cited by 1,122 · see citing works
The IBD interactome: an integrated view of aetiology, pathogenesis and therapy
de Souza, H. S. P., Fiocchi, C., & Iliopoulos, D. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.110 · Cited by 447 · see citing works
Big data in IBD: a look into the future
Olivera, P., Danese, S., Jay, N., Natoli, G., & Peyrin-Biroulet, L. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0102-5 · Cited by 151 · see citing works
Szigethy, E. M., Allen, J. I., Reiss, M., Cohen, W., Perera, L. P., Brillstein, L., Cross, R. K., Schwartz, D. A., Kosinski, L. R., Colton, J. B., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.037 · Cited by 107 · see citing works
Immune-mediated inflammatory diseases: common and different pathogenic and clinical features
Monteleone, G., Moscardelli, A., Colella, A., Marafini, I., & Salvatori, S. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103410 · Cited by 105 · see citing works
- Authors
- Abreu, M. T., Taylor, K. D., Lin, Y.-C., Hang, T., Gaiennie, J., Landers, C. J., Vasiliauskas, E. A., Kam, L. Y., Rojany, M., Papadakis, K. A., Rotter, J. I., Targan, S. R., & Yang, H.
- Affiliations
- Cedars-Sinai Medical Center (US)
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 123
- Issue
- 3
- Pages
- 679-688
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W4231022815
- Cited by
- 428
- References
- 49
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 5 · 2020: 7 · 2019: 9 · 2018: 10 · 2017: 14 · 2016: 12 · 2015: 9 · 2014: 16 · 2013: 20 · 2012: 15
- FWCI
- 21.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (5r01dk054967-04)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, DK-46763, DK 54967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Health Sciences › Medicine › Epidemiology › Autoimmune and Inflammatory Disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- NOD2 mutations, Crohn's disease, small bowel diseases, genotype-phenotype correlation, inflammatory bowel disease, disease location
- MeSH terms
- Adolescent, Adult, Aged, Alleles, Carrier Proteins, Child, Child, Preschool, Constriction, Pathologic, Crohn Disease, Female, Fibrosis, Gene Frequency, Genotype, Humans, Intestines, Male, Middle Aged, Mutation, Phenotype, Cohort Studies, Intracellular Signaling Peptides and Proteins, Nod2 Signaling Adaptor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
